---
schema_version: "secwatch.filing_event.v1"
accession: "0001551163-22-000057"
form_type: "8-K"
ticker: null
cik: "0001104280"
company_name: "SANGUI BIOTECH INTERNATIONAL INC"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T07:54:06.788231+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sangui BioTech delisted from OTCQB to Pink Market after failing $0.01 bid-price rule

## Summary
- OTC Markets commenced delisting from OTCQB for non-compliance with minimum closing bid price of $0.01 per share for 30 days.
- Effective November 2, 2022, common stock moved to the Pink Market and continues to trade under symbol 'SGBI'.
- Company intends to maintain current SEC reporting obligations despite the transfer.

## SEC filing metadata
- accession: 0001551163-22-000057
- form_type: 8-K
- cik: 0001104280
- company_name: SANGUI BIOTECH INTERNATIONAL INC
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1104280/000155116322000057/0001551163-22-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1104280/000155116322000057/sgbi8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551163-22-000057
- JSON: https://secwatch.observer/filing/0001551163-22-000057.json
- Plain text: https://secwatch.observer/filing/0001551163-22-000057.txt

## Key facts
- Listing & Compliance Notices
  SANGUI BIOTECH INTERNATIONAL INC received a otc delisting notice notice regarding minimum bid price.
  - Exchange: otc
  - Notice: delisting notice
  - Deficiency: minimum bid price
  source text: October 31, 2022, Sangui BioTech International, Inc. (the “Company” or “Sangui”) was notified by the OTC Markets Group (the “OTC”) that the OTC had determined to commence proceedings to delist its common stock (the “Common Stock”) from the OTCQB as a result of the Company’s failure to comply with the continued listing standard set forth in the OTCQB Standards, Section 2.3(2) which states that the company must “maintain proprietary priced quotations published by a Market Maker in OTC Link with a minimum closing bid price of $.01 per share on at least one of the prior thirty consecutive calendar
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104280/000155116322000057/0001551163-22-000057-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.